Results-Financial Results for September 30,2026.

Date: October 23, 2026. To, To, BSE Limited, National Stock Exchange of India Limited, Department of Corporate Services, The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Mumbai-400001 Bandra Kurla Complex, Mumbai-400051 Scrip Code: 544545 Symbol: TRUALT Sub: Intimation under Regulation 30(6) and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Standalone and Consolidated Unaudited Financial Results for the Quarter and Half Year ended on September 30, 2026. Dear Sir/Madam, Pursuant to our intimation dated October 14, 2026, and in terms of the provision of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the meeting of Board of Directors of TruAlt Bioenergy Limited (the “Company”) was held today, i.e. Friday, October 23, 2026. Based on the recommendation of the Audit Committee, the Board has approved the Unaudited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Half Year ended on September 30, 2026 along with the Limited Review Report thereon. Financial Results together with Limited Review Report issued by M/s N. M. Raiji & Co. are enclosed herewith as Annexure I. The advertisement will also be published in the newspaper, in accordance with the Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, containing a Quick Response (QR) Code and details of the webpage where the complete financial results of the Company, along with the Limited Review Report, will be available. The meeting commenced at 04:40 p.m. (IST) and concluded at 5:14 p.m. (IST) Further the aforementioned information will also be made available on the Company’s website at www.trualtbioenergy.com We request you to kindly take the above on record. Yours faithfully, For TruAlt Bioenergy Limited Vijaykumar Murugesh Nirani Managing Director. DIN:07413777 Encl.: As above. Annexure I Independent Auditor's Review Report on the Quarterly and Year to Date Unaudited Standalone Financial Results of TruAlt Bioenergy Limited, pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To the Board of Directors TruAlt Bioenergy Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of TruAlt Bioenergy Limited ("the Company"), for the quarter ended September 30, 2026, and the year to date results for the period from April 1, 2026, to September 30, 2026 ("the Statement"), together with the relevant notes thereon, attached herewith, being submitted by the Company, pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). 2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("lnd AS 34"), prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. Scope of the Review 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013, and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. We have not performed an audit and accordingly, we do not express an audit opinion. N. M. RAIJI & CO. Conclusion 4. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Other Matter 5. Attention is drawn to the fact that the figures for the quarter ended September 30, 2026, as reported in the Statement, are the balancing figures between the unaudited standalone financial results for the half year ended September 30, 2026, and the unaudited standalone financial results for the quarter ended June 30, 2026. Our conclusion on the unaudited standalone financial results is not modified in respect of this matter. For N. M. Raiji & Co. Chartered Accountants Firm Registration No.: 108296W Vinay D. Balse Partner Membership No.: 039434 UDIN: 26039434LHSBWD4871 Place: Mumbai Date: October 23, 2026 Independent Auditor’s Review Report on the Quarterly and Year to Date Unaudited Consolidated Financial Results of TruAlt Bioenergy Limited (“the Holding Company”), pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. To The Board of Directors TruAlt Bioenergy Limited 1. We have reviewed the accompanying statement of unaudited consolidated financial results of TruAlt Bioenergy Limited (“the Holding Company”) and its subsidiaries – Leafiniti Bioenergy Private Limited and TruAlt Sumi Gas Private Limited (Formerly known as TruAlt Gas Private Limited) (the Holding Company and its subsidiaries together referred to as the “Group”), for the quarter ended September 30, 2026, and the year to date results for the period from April 1, 2026, to September 30, 2026, together with the relevant notes thereon, (“the Statement”), being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). 2. This Statement, which is the responsibility of the Holding Company’s Management and has been approved by the Holding Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’), as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. Scope of the Review 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company person [Showing first 8,000 characters — download PDF for full document]